Nyvec confirms potential to alleviate kidney and heart fibrosis, unveils preclinical data at US conference
Predicted impact: Low
Preclinical data at a conference is early-stage and vague for valuation.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.